Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Expression of
galectin-3
is associated with sarcoma progression, invasion and metastasis. Here we determined the role of extracellular
galectin-3
on migration of sarcoma cells on laminin-111. Cell lines from methylcholanthrene-induced sarcomas from both wild type and
galectin-3
(-/-) mice were established. Despite the presence of similar levels of laminin-binding integrins on the cell surface,
galectin-3
(-/-) sarcoma cells were more adherent and less migratory than
galectin-3
(+/+) sarcoma cells on laminin-111. When
galectin-3
was transiently expressed in
galectin-3
(-/-) sarcoma cells, it inhibited cell adhesion and stimulated the migratory response to laminin in a carbohydrate-dependent manner. Extracellular
galectin-3
led to the recruitment of SHP-2 phosphatase to focal adhesion plaques, followed by a decrease in the amount of phosphorylated FAK and phospho-
paxillin
in the lamellipodia of migrating cells. The promigratory activity of extracellular
galectin-3
was inhibitable by wortmannin, implicating the activation of a PI-3 kinase dependent pathway in the
galectin-3
triggered disruption of adhesion plaques, leading to sarcoma cell migration on laminin-111.
...
PMID:The promigratory activity of the matricellular protein galectin-3 depends on the activation of PI-3 kinase. 2221 45
The presence and level of circulating
galectin-3
(Gal-3), a member of the galectin family, is associated with diverse diseases ranging from heart failure, immune disorders to cancer metastasis and serves as a biomarker of diagnosis and treatment response. However, the mechanisms by which exogenous Gal-3 affects pathobiology events remain elusive. In the current study, we found that exogenous Gal-3 slightly delays, while prolonging tyrosine phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) in HeLa cells through a calcium-sensitive and PKC-dependent signaling pathway. The activation was dependent on the sugar-binding properties of Gal-3, since the antagonist lactose could inhibit it. The sugar-binding motif of Gal-3 was required for the activation of ERK1/2. The activation of ERK1/2 was necessary for the initiation and induction of cell migration associated with the phosphorylation of
paxillin
. All the results presented in this study suggest a novel calcium-sensitive and PKC-dependent pathway through which circulating Gal-3 promotes cell migration and activating the ERK1/2. Taken together, the data depicted here propose a biological function and a target for the diseases' associated circulating Gal-3.
...
PMID:Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway. 2480 57